See more : Hydract A/S (HYDRCT.CO) Income Statement Analysis – Financial Results
Complete financial analysis of P3 Health Partners Inc. (PIII) income statement, including revenue, profit margins, EPS and key performance metrics. Get detailed insights into the financial performance of P3 Health Partners Inc., a leading company in the Medical – Care Facilities industry within the Healthcare sector.
- China Public Procurement Limited (1094.HK) Income Statement Analysis – Financial Results
- Al Majed Oud Co. (4165.SR) Income Statement Analysis – Financial Results
- Snam S.p.A. (SNMRY) Income Statement Analysis – Financial Results
- Tire Company Debica S.A. (DBC.WA) Income Statement Analysis – Financial Results
- HIMALAYA FOOD INTERNATIONAL LI (HFIL.BO) Income Statement Analysis – Financial Results
P3 Health Partners Inc. (PIII)
About P3 Health Partners Inc.
P3 Health Partners Inc., a patient-centered and physician-led population health management company, provides superior care services in the United States. It operates clinics and wellness centers. The company is based in Henderson, Nevada.
Metric | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 |
---|---|---|---|---|---|---|
Revenue | 1.27B | 1.05B | 491.06B | 485.54M | 145.48M | 87.70M |
Cost of Revenue | 1.23B | 1.14B | 668.07M | 485.30M | 141.03M | 0.00 |
Gross Profit | 31.64M | -95.01M | 490.40B | 243.70K | 4.45M | 87.70M |
Gross Profit Ratio | 2.50% | -9.05% | 99.86% | 0.05% | 3.06% | 100.00% |
Research & Development | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
General & Administrative | 122.36M | 157.30M | 53.39B | 53.39M | 36.42M | 28.54M |
Selling & Marketing | 3.23M | 5.10M | 1.50B | 1.50M | 801.69K | 1.87M |
SG&A | 125.60M | 162.40M | 54.89B | 54.89M | 37.23M | 30.41M |
Other Expenses | 73.97M | 1.13B | 464.76B | 465.77M | 147.79M | -103.73K |
Operating Expenses | 199.57M | 1.30B | 519.65B | 520.66M | 185.02M | 137.41M |
Cost & Expenses | 1.43B | 1.30B | 519.65B | 520.66M | 185.02M | 137.41M |
Interest Income | 0.00 | 11.40M | 0.00 | 2.53M | 2.53M | 0.00 |
Interest Expense | 15.99M | 11.40M | 10.68M | 2.53M | 2.53M | 0.00 |
Depreciation & Amortization | 86.68M | 87.29M | 8.72M | 795.17K | 399.18K | 342.20K |
EBITDA | -81.07M | -1.46B | -184.61M | -28.08M | -39.04M | -49.37M |
EBITDA Ratio | -6.40% | -14.85% | -6.40% | -7.07% | -26.83% | -56.30% |
Operating Income | -167.86M | -1.56B | -31.41B | -35.12M | -39.54M | -49.71M |
Operating Income Ratio | -13.26% | -148.73% | -6.40% | -7.23% | -27.18% | -56.69% |
Total Other Income/Expenses | -15.87M | 1.22M | -31.22B | -2.82M | -2.44M | -59.50K |
Income Before Tax | -183.73M | -1.56B | -31.41B | -45.38M | -41.97M | -49.77M |
Income Before Tax Ratio | -14.51% | -148.60% | -6.40% | -9.35% | -28.85% | -56.76% |
Income Tax Expense | 2.70M | 1.90M | -31.40B | -4.00M | 2.63M | -6.02M |
Net Income | -57.77M | -270.13M | -10.08M | -31.41M | -41.97M | -43.80M |
Net Income Ratio | -4.56% | -25.74% | 0.00% | -6.47% | -28.85% | -49.95% |
EPS | -0.61 | -6.50 | -0.24 | -0.79 | -0.88 | -0.64 |
EPS Diluted | -0.20 | -6.50 | -0.24 | -0.79 | -0.88 | -0.64 |
Weighted Avg Shares Out | 94.89M | 41.58M | 41.58M | 39.53M | 47.59M | 68.16M |
Weighted Avg Shares Out (Dil) | 294.59M | 41.58M | 41.58M | 39.53M | 47.59M | 68.16M |
P3 Health Partners to Present at the KeyBanc LifeSciences & Medtech Investor Forum
P3 Health Partners to Participate in the Jefferies Value Based Healthcare Summit
P3 Health Partners to Present at the TD Cowen 44th Annual Healthcare Conference
P3 Health Partners to Participate in The 2024 BTIG MedTech, Digital Health, Life Science & Diagnostic Tools Conference
P3 Health Partners stock pops on bullish 2024 revenue guidance
P3 Health Partners Reaffirms Guidance for 2023 and Announces Guidance for 2024
3 Medical Info Systems Stocks to Buy as Industry Rebounds
P3 Health Partners to Present at the 42nd Annual J.P. Morgan Healthcare Conference
P3 Health Partners to Present at the BTIG Digital Health Forum
P3 Health Partners Inc. (PIII) Q3 2023 Earnings Call Transcript
Source: https://incomestatements.info
Category: Stock Reports